JPRN-UMIN000031765已完成1 期
Treatment of sialorrhea by combined use of muscarinic M1 and M3 receptor selective antagonists - Treatment of sialorrhea by combined use of muscarinic M1 and M3 receptor selective antagonists
Tokyo Women's medical university0 个研究点目标入组 6 人开始时间: 2018年4月1日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 6
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 90years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •retention sialorrhea
研究者
相似试验
尚未招募
1 期
A study of musk in the treatment of microcirculation disorder after PPCI in acute ST-segment elevation myocardial infarctioAcute ST-segment elevation myocardial infarctionITMCTR2000003817onghua Hospital affiliated to Shanghai University of Traditional Chinese Medicine
已完成
不适用
Anti-Muscarinic Agents Alone and in Combination With a Muscarinic Agonist in Subjects with Overactive Bladder(OAB) SymptomsOveractive BladderJPRN-UMIN000007108Department of Urology, Nihon University Itabashi Hospital18
招募中
2 期
The effect of Silybum Marianum on treatment of migraineMigraine.MigraineIRCT2016022026667N1Arak University of Medical Sciences60
已完成
不适用
Clinical evaluation of T-AYU-HM Premium in sickle cell anemia patients: A Retrospective StudyCTRI/2022/02/040601Dhanvantari Clinic Ayurveda Health Care Research Center200
已完成
不适用
The efficacy and safety of long-acting muscarinic antagonist (LAMA) and long-acting beta2-agonist (LABA) in COPD patients with benign prostatic hyperplasia (BPH)JPRN-UMIN000009357Hamamatsu University School of Medicine30